Accès à distance ? S'identifier sur le proxy UCLouvain
Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
Primary tabs
Document type | Article de périodique (Journal article) – Letter |
---|---|
Publication date | 2005 |
Journal information | "Thrombosis and haemostasis" - Vol. 94, no. 3, p. 690-1 (2005) |
Peer reviewed | yes |
issn | 0340-6245 |
Publication status | Publié |
Affiliation | UCL - MD/ESP - Ecole de santé publique |
MESH Subject | Administration, Oral ; Aged ; Alleles ; Anticoagulants - administration & dosage - adverse effects - therapeutic use ; Case-Control Studies ; Female ; Genetic Variation ; Genotype ; Hemorrhage - chemically induced ; Humans ; Male ; Mixed Function Oxygenases - genetics ; Overdose ; Polymorphism, Single Nucleotide ; Prospective Studies ; Risk Factors ; Thrombosis - drug therapy |
Links |
Bibliographic reference | Quteineh, Lina ; Verstuyft, Celine ; Descot, Christelle ; Dubert, Liliane ; Robert, Annie ; et. al. Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.. In: Thrombosis and haemostasis, Vol. 94, no. 3, p. 690-1 (2005) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/25824 |